Fulltext

Corrigendum to 'Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach' [European Journal of Pharmaceutical Sciences 155 (2020) 105537]

Mirza MU 1 , Saadabadi A 2 , Vanmeert M 1 , Salo-Ahen OMH 2 , Abdullah I 3 , Claes S 4 Show all authors , De Jonghe S 4 , Schols D 4 , Ahmad S 3 , Froeyen M 5

Affiliations 

  • 1 Medicinal Chemistry, Department of Pharmaceutical and Pharmacological Sciences, Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium
  • 2 Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Pharmacy, Åbo Akademi University, FI-20520 Turku, Finland; Structural Bioinformatics Laboratory, Faculty of Science and Engineering, Biochemistry, Åbo Akademi University, FI-20520 Turku, Finland
  • 3 Department of Chemistry, Faculty of Sciences, University Malaya, Kuala Lumpur 59100, Malaysia
  • 4 Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium
  • 5 Medicinal Chemistry, Department of Pharmaceutical and Pharmacological Sciences, Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium. Electronic address: matheus.froeyen@kuleuven.be
Eur J Pharm Sci, 2021 Jul 01;162:105827.
PMID: 33814256 DOI: 10.1016/j.ejps.2021.105827

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications